Number of shares outstanding for NeoGenomics (NEO)

Number of shares outstanding as of December 2024 : 126,953,000

According to NeoGenomics 's latest financial reports and stock price the company's current number of shares outstanding is 126,953,000. At the end of 2024 the company had 126,953,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for NeoGenomics from 1999 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	0.12 B	1.01%
2023	0.12 B	0.78%
2022	0.12 B	1.33%
2021	0.12 B	10.69%
2020	0.11 B	6.52%
2019	0.10 B	11.93%
2018	93.27 M	7.61%
2017	86.67 M	10.43%
2016	78.49 M	28.97%
2015	60.85 M	1.36%
2014	60.04 M	22.48%
2013	49.02 M	8.51%
2012	45.17 M	4.8%
2011	43.1 M	15.32%
2010	37.37 M	3.82%
2009	36 M	14.51%
2008	31.44 M	0.42%
2007	31.3 M	17.7%
2006	26.59 M	18.08%
2005	22.52 M	8.37%
2004	20.78 M	12.66%
2003	18.44 M	330.27%
2002	4.28 M	79.78%
2001	2.38 M	1191.62%
2000	0.18 M	-56.04%
1999	0.42 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
RadNet RDNT	73,494,709	-42.11%	🇺🇸 USA
Psychemedics PMD	5,894,000	-95.36%	🇺🇸 USA
Quest Diagnostics DGX	112,000,000	-11.78%	🇺🇸 USA
LabCorp LH	84,000,000	-33.83%	🇺🇸 USA
Enzo Biochem ENZ	52,244,000	-58.85%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions